Nobilis Health (AMEX:HLTH)
Historical Stock Chart
1 Year : From Jan 2019 to Jan 2020
Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of
Nobilis Health Corp. (“Nobilis” or “the Company”) (NYSE: HLTH)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
The investigation focuses on whether the Company issued false and/or
misleading statements and/or failed to disclose information pertinent to
investors. Both Nobilis’ revenue and accounts receivable were
overstated. The need to adjust financials caused the Company’s quarterly
report to not be filed in a timely manner, leaving the Company at risk
of not maintaining compliance with NYSE listing requirements. Based on
these facts, the Company’s public statements were false and materially
misleading throughout the class period. When the market learned the
truth about Nobilis, investors suffered damages.
If you are a shareholder who suffered a loss, click
here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm's website at www.schallfirm.com,
or by email at email@example.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190208005363/en/
The Schall Law FirmBrian Schall, Esq.Sherin Mahdavian, Esq.310-301-3335Cell: